Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Transporters Comprising Spaced Arginine Moieties

a technology of transporters and arginine moieties, which is applied in the direction of peptides, drug compositions, peptides, etc., can solve the problems of inability to efficiently access intracellular targets and hinder medicinal utility, and achieve the effect of enhancing transport and enhancing transport of biologically active compounds

Inactive Publication Date: 2010-04-01
WENDER PAUL A +4
View PDF13 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a way to help move important compounds across cell membranes and into animal tissues. This is done by combining a biological active ingredient with a transport molecule that has a specific structure. The transport molecule is made up of L-arginine or D-arginine and an amino acid that doesn't have certain properties. The method involves giving this combination to animals."

Problems solved by technology

There are a number of natural barriers that exist in living organisms.
Unfortunately, barriers such as cellular membranes function by excluding chemical compounds possessing particular physical characteristics rather than by specifically repelling harmful compositions.
This can be problematic in the field of drug discovery where one is targeting a biopolymer encased in the barrier.
When one administers a highly charged compound (e.g., oligonucleotide) to an organism, its medicinal utility is hindered by its inability to efficiently access its intracellular target.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transporters Comprising Spaced Arginine Moieties
  • Transporters Comprising Spaced Arginine Moieties
  • Transporters Comprising Spaced Arginine Moieties

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0102]This example illustrates the synthesis of various peptides, including those having attached linking groups which are natural or non-natural amino acids.

[0103]Peptides were synthesized using solid phase techniques and commercially available Fmoc amino acids, resins, and reagents (PE Biosystems, Foster City Calif., and Bachem Torrence, Calif.) on a Applied Biosystems 433 peptide synthesizer. Fmoc amino caproic acid and Fmoc amino butyric acid were purchased from NovaBiochem (San Diego, Calif.). Fastmoc cycles were used with O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexyluorophosphate (HATU) substituted for HBTU / HOBt as the coupling reagent. The peptides were cleaved from the resin using 96% trifluoroacetic acid, 2% triisopropyl silane, and 2% phenol for 12 hours. The longer reaction times were necessary to completely remove the Pbf protecting groups from the multiple arginines in the peptides. The peptides subsequently were filtered from the resin, precipitated using...

example 2

[0106]This example illustrates a cellular uptake assay which can be used to evaluate the conjugates of the present invention.

[0107]The fluorescently labeled peptides were dissolved in PBS, pH 7.2, and their concentrations were determined by absorption of fluorescein at 490 nm (c=67,000). The human T cell line, Jurkat, grown in 10% fetal calf serum in DMEM, was used for all the cellular uptake experiments. Varying amounts of the peptides were added to 3×105 cells in a total of 200λ, in wells of microtiter plates, and incubated for varying periods of time, ranging from three to five minutes. The cells were spun, washed three times with cold PBS, incubated with 0.05% trypsin / 0.53 mM EDTA (Gibco, Grand Island, N.Y.) at 37° C. for five minutes, washed with PBS, and resuspended in PBS containing 0.1% propidium iodide. The cells were analyzed either using confocal microscopy or fluorescent flow cytometry (FACScan, Becton Dickinson, Milpitas, Calif.). Cells staining with propidium iodide we...

example 3

[0108]This example provides results of arginine spacing in the cellular uptake assay of Example 2.

[0109]3A—Comparison of R7 Homopolymer with Single Amino Acid Spacing (no Side Chains)

[0110]A series of arginine containing conjugates was prepared as described in Example 1 and evaluated as described in Example 2. Spacing between seven arginine residues was provided by glycine (see Seq. I.D. No. 4), γ-aminobutyric acid (see Seq. I.D. No. 5), and ε-aminocaproic acid (see Seq. I.D. No. 6). FIG. 1 shows the results of cellular uptake for the “spaced” arginine transport moieties when tethered to fluorescein. As can be seen from this figure, cellular uptake generally increases when spacing increases (ε-aminocaproic acid>γ-aminobutyric acid>glycine.

[0111]3B—Comparison of R7 Homopolymer with Naturally-Occurring Single Amino Acid Spacing

[0112]A series of arginine containing conjugates was prepared as described in Example 1 and evaluated as described in Example 2. Spacing between seven arginine ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
MWaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention provides compositions and methods for enhancing transport of biologically active compounds across biological membranes and across and into animal epithelial or endothelial tissues. The composition includes a biologically active agent and a transport moiety. The transport moiety includes a structure selected from the group consisting of (ZYZ)nZ, (ZY)nZ, (ZYY)nZ and (ZYYY)nZ. Subunit “Z” is L-arginine or D-arginine, and subunit “Y” is an amino acid that does not comprise an amidino or guanidino moiety. Subscript “n” is an integer ranging from 2 to 10. The method for enhancing transport involves the administration of the aforementioned composition.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of U.S. Ser. No. 10 / 078,247, filed Feb. 14, 2002, which claims the benefit of U.S. Ser. No. 60 / 269,627, filed Feb. 16, 2001. The disclosures of the aforementioned applications are incorporated in their entireties by reference herein.STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT[0002]This invention was made with the support of NIH grants numbered CA31841, CA31845, and CA65237. Accordingly, the U.S. Government has certain rights in this invention.BACKGROUND OF THE INVENTION[0003]There are a number of natural barriers that exist in living organisms. The barriers most likely developed over time as a mechanism to exclude harmful stimuli, such as toxic chemicals, from sensitive biochemical pathways. Cellular membranes, epithelial tissues and endothelial tissues are examples of such barriers.[0004]Unfortunately, barriers such as cellular membranes function by excl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/16A61K38/10A61K38/08A61P43/00A61K31/522A61K38/00A61K47/48A61P31/12A61P35/00C07K7/06C07K7/08C07K14/00
CPCA61K47/48246A61K47/64A61P31/12A61P35/00A61P43/00
Inventor WENDER, PAUL A.ROTHBARD, JONATHAN B.WRIGHT, LEEKREIDER, ERIK L.VANDEUSEN, CHRISTOPHER L.
Owner WENDER PAUL A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com